Nathan L. Shipkowitz
Nathan L. Shipkowitz publishes mostly in Epidemiology, Organic Chemistry and Molecular Medicine, on topics such as Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy and Pneumonia and Respiratory Infections.
- World rank
- #1,568,358 of 7,710,434 ranked researchers
- Rank in United States
- #489,012 of 1,627,098
- Works
- 32
- Citations
- 1.3k
- Citations per work
- 39.3
What does Nathan L. Shipkowitz research?
Nathan L. Shipkowitz's work is mostly in Medicine (33%), Biochemistry, Genetics and Molecular Biology (20%), Chemistry (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1133.0%
- Medicine1133.0%
- Everything else1132.9%
- Life Sciences619.8%
- Physical Sciences514.3%
- Chemistry514.3%
- 1Epidemiology16% of their works
- 2Organic Chemistry14% of their works
- 3Molecular Medicine12% of their works
- 4Pharmacology9% of their works
- 5Infectious Diseases8% of their works
- 6Molecular Biology8% of their works
Research topics
- Antibiotic Resistance in Bacteria
- Antibiotics Pharmacokinetics and Efficacy
- Pneumonia and Respiratory Infections
- Cancer therapeutics and mechanisms
- Phenothiazines and Benzothiazines Synthesis and Activities
- Antimicrobial Resistance in Staphylococcus
- HIV/AIDS drug development and treatment
- Synthesis and Characterization of Heterocyclic Compounds
Which keywords describe Nathan L. Shipkowitz's research?
The keywords of their largest research topics: Antimicrobial Resistance, Antibiotic Resistance, Multidrug-Resistant Bacteria, Epidemiology, Antibiotic Pharmacokinetics, Critically Ill Patients, Community-Acquired Pneumonia and Pneumococcal Conjugate Vaccine.
- Triazines
- Topoisomerases
- Phenothiazines
- HIV Infection
- Biological Activities
- Synthesis
- Pneumococcal Conjugate Vaccine
- Critically Ill Patients
- Epidemiology
- Antibiotic Resistance
- Antimicrobial Resistance
- Multidrug-Resistant Bacteria
- Antibiotic Pharmacokinetics
- Community-Acquired Pneumonia
- Antimicrobial
- Antiretroviral Therapy
- DNA
- MRSA
- Staphylococcus aureus
- Biological Evaluation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Antimicrobial Resistance173 topics
- Antibiotic Resistance111 topic
- Multidrug-Resistant Bacteria111 topic
- Epidemiology92 topics
- Antibiotic Pharmacokinetics81 topic
- Critically Ill Patients81 topic
- Community-Acquired Pneumonia61 topic
- Pneumococcal Conjugate Vaccine61 topic
- Antimicrobial52 topics
- Synthesis52 topics
- Antiretroviral Therapy31 topic
- Biological Activities31 topic
- DNA31 topic
- HIV Infection31 topic
- MRSA31 topic
- Phenothiazines31 topic
- Staphylococcus aureus31 topic
- Topoisomerases31 topic
- Biological Evaluation21 topic
- Triazines21 topic
Where does Nathan L. Shipkowitz work?
Nathan L. Shipkowitz's main affiliation in the publication record is Abbott Fund, United States.
How many publications and citations does Nathan L. Shipkowitz have?
OpenAlex counts 32 works and 1,259 citations for Nathan L. Shipkowitz, an h-index of 20, ranking #1,568,358 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Nathan L. Shipkowitz. Posts are plain text and can be reported.